New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.When John Ebers, a commercial beekeeper in Comstock Park, Mich., was diagnosed with Stage 3 colorectal cancer, he was not given the option of genetic testing, which could have revealed if there were drugs that could attack his cancer.